-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Initiates Coverage On Ionis Pharmaceuticals with Buy Rating, Announces Price Target of $115

Benzinga·05/19/2026 14:27:55
Listen to the news
Citigroup analyst Eric Joseph initiates coverage on Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy rating and announces Price Target of $115.